A greater proportion of psychiatric and rheumatologic disorders are associated with FMS patients than the population. Consequently, physicians treating patients with either condition should keep in mind that these patients may have such comorbidities and should be treated accordingly.

BackgroundThe fibromyalgia syndrome (FMS) is a chronic condition consisting of widespread musculoskeletal pain and tenderness together with mood and cognitive dysfunction. Diabetes mellitus (DM) is a common condition causing significant and detrimental morbidity and mortality. Data on the association between the two conditions is scarce and mainly based on small populations therefore lack solid evidence.ObjectivesTo evaluate the association of FMS with DM.Material and methodsThis cross-sectional study used the Clalit Health Services database, the largest Health Maintenance Organization in Israel, serving 4,400,000 members. FMS patients were compared to age- and sex-matched controls regarding chronic comorbid conditions. χ2 and student’s t-tests were used for univariate analysis.ResultsThe study included 14,296 FMS patients and 71,324 age- and sex-matched controls. The FMS group had a significantly higher proportion of DM patients compared to non-FMS controls (19.8% and 17.4 respectively; OR 1.17 , 95% CI: 1.12–1.23, p < 0.001).ConclusionsDM was found to be more common amongst FMS patients compared to matched controls to suggest that the pathophysiology of DM might lead a patient to develop FMS. Consequently, physicians treating DM patients should be aware of the possible risk and asses for clinical signs of FMS in order to diagnose and treat it in time to better their patients’ quality of life and disease management.

Purpose The mechanism by which preoperative expectations may be associated with patient satisfaction and procedural outcomes following hip preservation surgery (HPS) is far from simple or linear. The purpose of this study is to better understand patient expectations regarding HPS and their relationship with patient-reported outcomes (PROs) and satisfaction using machine learning (ML) algorithms. Methods Patients scheduled for hip arthroscopy completed the Hip Preservation Surgery Expectations Survey (HPSES) and the pre-and a minimum 2 year postoperative International Hip Outcome Tool (iHOT-33). Patient demographics, including age, gender, occupation, and body mass index (BMI), were also collected. At the latest follow-up, patients were evaluated for subjective satisfaction and postoperative complications. ML algorithms and standard statistics were used. Results A total of 69 patients were included in this study (mean age 33.7 ± 13.1 years, 62.3% males). The mean followup period was 27 months.

BackgroundFibromyalgia syndrome (FMS) is defined as chronic widespread musculoskeletal pain and tenderness with concomitant mood and cognitive dysfunction. Several comorbidities have been reported to be associated with FMS. However, these studies are mostly based on small populations and lack solid evidence.ObjectivesTo evaluate the association of FMS with Cancer diagnoses.MethodsThis cross-sectional study used the database of the largest Health Maintenance Organisation in Israel, Clalit Health Services, serving more than 4 million members. FMS patients were compared to age- and sex-matched controls regarding comorbid Cancer diagnoses. Chi-square and t-tests were used for univariate analysis,.ResultsOur study utilised data from 14,296 FMS patients and 71 324 age- and sex-matched controls. FMS patients compared to controls had a higher proportion of the following types of cancer: Cervix and Uteri, Connective Tissue Sarcoma, Thyroid, Non Hodgkin Lymphoma (NHL) and Benign brain tumours (OR=1.39, 1.60, 1.68, 1.26, 1.87 respectively, P value<0.005) – See table 1.Figure 1BMI: Body mass index, kg/m2; SES: Socioeconomic statusConclusionsStudy results show a higher proportion of malignancy diagnoses amongst FMS patients compared to matched controls. Accordingly, in treating FMS patients, physicians should bear in mind the likelihood of concomitant tumour as it might explain various FMS symptoms, and more importantly, shorten a patients‘ time for diagnosis and treatment of the oncological condition.Disclosure of InterestNone declared